GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InVivo Therapeutics Holdings Corp (FRA:04I) » Definitions » 12-1 Month Momentum %

InVivo Therapeutics Holdings (FRA:04I) 12-1 Month Momentum % : -70.36% (As of May. 21, 2024)


View and export this data going back to 2015. Start your Free Trial

What is InVivo Therapeutics Holdings 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-21), InVivo Therapeutics Holdings's 12-1 Month Momentum % is -70.36%.

The industry rank for InVivo Therapeutics Holdings's 12-1 Month Momentum % or its related term are showing as below:

FRA:04I's 12-1 Month Momentum % is ranked worse than
85.35% of 1481 companies
in the Biotechnology industry
Industry Median: -26.73 vs FRA:04I: -70.36

Competitive Comparison of InVivo Therapeutics Holdings's 12-1 Month Momentum %

For the Biotechnology subindustry, InVivo Therapeutics Holdings's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InVivo Therapeutics Holdings's 12-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, InVivo Therapeutics Holdings's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where InVivo Therapeutics Holdings's 12-1 Month Momentum % falls into.



InVivo Therapeutics Holdings  (FRA:04I) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


InVivo Therapeutics Holdings  (FRA:04I) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


InVivo Therapeutics Holdings 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of InVivo Therapeutics Holdings's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


InVivo Therapeutics Holdings (FRA:04I) Business Description

Traded in Other Exchanges
Address
One Kendall Square, Suite B14402, Building 1400 West, 4th Floor, Cambridge, MA, USA, 02139
InVivo Therapeutics Holdings Corp is a research and clinical stage biomaterials and biotechnology company. It focuses on the treatment of spinal cord injury. The company's product pipeline consists of Neuro spinal scaffold and Bioengineered neural trails. The firm has a clinical development program for acute spinal cord injury and a preclinical development program for chronic spinal cord injury.

InVivo Therapeutics Holdings (FRA:04I) Headlines

No Headlines